ABT-199, CAS 1257044-40-8

ABT-199, CAS 1257044-40-8
Artikelnummer
CAY16233-100
Verpackungseinheit
100 mg
Hersteller
Cayman Chemical

Verfügbarkeit: wird geladen...
Preis wird geladen...
Formulation: A crystalline solid

Formal Name: 4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-benzamide

Purity: ≥98%

Formula Markup: C45H50ClN7O7S

Formula Weight: 868,4

Shelf life (days): 1460

CAS Number: 1257044-40-8

Notes: B-cell lymphoma/leukemia 2 (Bcl-2) is an anti-apoptotic protein that controls cell survival by binding the BH3 domains of pro-death BAD and BAK proteins and preventing permeabilization of the mitochondrial outer membrane. This protein is tightly regulated for the homeostasis between cell growth and cell death. The gene that encodes this protein is considered an oncogene; its disruption can promote the survival of cancer cells.{27581} ABT-199 is a BH3 mimetic that selectively inhibits Bcl-2 with subnanomolar affinity (Ki is = 48 and 245 nM, respectively).{27580} ABT-199 inhibits the growth of Bcl-2-dependent cell lines and in vivo tumor xenografts.{27580} This compound has shown antileukemic activity in patients with refractory chronic lymphocytic leukemia and holds promise to address additional Bcl-2-dependent cancers.{27580,27583,27583}
Mehr Informationen
Artikelnummer CAY16233-100
Hersteller Cayman Chemical
Hersteller Artikelnummer 16233-100
Green Labware Nein
Verpackungseinheit 100 mg
Mengeneinheit STK
Methode Reinstoffe
Produktinformation (PDF) Download
MSDS (PDF) Download